Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

891
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
891
Viruses of Archaea01:29

Viruses of Archaea

488
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
488
Introduction to Virus01:28

Introduction to Virus

1.5K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
What are Viruses?00:50

What are Viruses?

127.9K
Overview
127.9K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

3.5K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality.

Cancer·2026
Same author

Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer Recurrence.

medRxiv : the preprint server for health sciences·2026
Same author

Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.

JCO oncology advances·2026
Same author

Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study.

The Lancet. Oncology·2026
Same author

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Racial disparity in pro-metastatic tumor microenvironment in treatment naïve breast cancer.

NPJ breast cancer·2026

Related Experiment Video

Updated: Jan 27, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.6K

Human immunodeficiency virus associated lymphoma.

Joseph A Sparano1

  • 1Albert Einstein College of Medicine and Cancer Center, Montefiore Medical Center, Bronx, New York 10461, USA. jsparano@montefiore.org

Current Opinion in Oncology
|September 10, 2003
PubMed
Summary
This summary is machine-generated.

Highly active antiretroviral therapy (HAART) has improved outcomes for patients with HIV-associated lymphoma. Advances in diagnosis and treatment offer curative potential, shifting from previous nihilistic approaches.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.7K

Related Experiment Videos

Last Updated: Jan 27, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.6K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.7K

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • HIV infection significantly increases the risk of systemic non-Hodgkin lymphoma, Hodgkin disease, and primary central nervous system lymphoma (PCNSL).
  • Lymphoma in HIV-infected individuals historically carried a poor prognosis.

Purpose of the Study:

  • To review recent advancements in the diagnosis and management of lymphoma in patients with HIV infection.
  • To highlight the impact of modern therapies on outcomes.

Main Methods:

  • Review of recent studies on HIV-associated lymphoma.
  • Analysis of the influence of highly active antiretroviral therapy (HAART) on lymphoma development and presentation.
  • Evaluation of combined HAART and chemotherapy, molecular classification, rituximab use, and novel Hodgkin disease strategies.

Main Results:

  • Highly active antiretroviral therapy (HAART) influences lymphoma development, clinical presentation, and treatment feasibility.
  • New insights into molecular classification and the role of rituximab in managing HIV-associated lymphoma.
  • Novel treatment strategies are emerging for Hodgkin disease in this population.

Conclusions:

  • The prognosis for HIV-associated lymphoma has significantly improved in the post-HAART era.
  • Therapeutic interventions are increasingly curative, marking a departure from past reduced-intensity approaches.
  • A shift towards more aggressive and potentially curative treatment strategies is evident.